Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Mikhaylov

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Archives of Dermatological Research|November 13, 2018
A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areataDaniela Mikhaylov, Ana Pavel, Christopher Yao, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 18, 2021
Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With DupilumabDaniela Mikhaylov, Ester Del Duca, Caroline Meyer Olesen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 5, 2021
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with DupilumabBenjamin Ungar, Jacob W Glickman, Alexandra K Golant, et al.
The Journal of Investigative Dermatology|April 14, 2022
Transcriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier SignaturesMadeline Kim, Daniela Mikhaylov, Stephanie M Rangel, et al.
Journal of the American Academy of Dermatology|February 11, 2023
Proteomic characterization of atopic dermatitis blood from infancy to adulthoodEster Del Duca, Yael Renert-Yuval, Ana B Pavel, et al.
Archives of Dermatological Research|March 1, 2022
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areataDaniela Mikhaylov, Jacob W Glickman, Ester Del Duca, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Archives of Dermatological Research|November 13, 2018
A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areataDaniela Mikhaylov, Ana Pavel, Christopher Yao, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 18, 2021
Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With DupilumabDaniela Mikhaylov, Ester Del Duca, Caroline Meyer Olesen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 5, 2021
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with DupilumabBenjamin Ungar, Jacob W Glickman, Alexandra K Golant, et al.
The Journal of Investigative Dermatology|April 14, 2022
Transcriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier SignaturesMadeline Kim, Daniela Mikhaylov, Stephanie M Rangel, et al.
Journal of the American Academy of Dermatology|February 11, 2023
Proteomic characterization of atopic dermatitis blood from infancy to adulthoodEster Del Duca, Yael Renert-Yuval, Ana B Pavel, et al.
Archives of Dermatological Research|March 1, 2022
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areataDaniela Mikhaylov, Jacob W Glickman, Ester Del Duca, et al.
Pageof 2